Geovax Labs Inc (GOVX)
1.41
-0.04
(-2.76%)
USD |
NASDAQ |
May 02, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Geovax Labs Enterprise Value: -3.303M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | -3.303M |
| April 30, 2024 | -3.411M |
| April 29, 2024 | -3.324M |
| April 26, 2024 | -3.368M |
| April 25, 2024 | -3.259M |
| April 24, 2024 | -3.107M |
| April 23, 2024 | -3.107M |
| April 22, 2024 | -3.086M |
| April 19, 2024 | -3.194M |
| April 18, 2024 | -3.151M |
| April 17, 2024 | -3.281M |
| April 16, 2024 | -3.129M |
| April 15, 2024 | -2.803M |
| April 12, 2024 | -2.738M |
| April 11, 2024 | -2.477M |
| April 10, 2024 | -2.369M |
| April 09, 2024 | -2.217M |
| April 08, 2024 | -2.325M |
| April 05, 2024 | -2.347M |
| April 04, 2024 | -2.086M |
| April 03, 2024 | -2.238M |
| April 02, 2024 | -2.282M |
| April 01, 2024 | -2.195M |
| March 28, 2024 | -2.108M |
| March 27, 2024 | -2.434M |
| Date | Value |
|---|---|
| March 26, 2024 | -2.456M |
| March 25, 2024 | -2.325M |
| March 22, 2024 | -2.173M |
| March 21, 2024 | -2.260M |
| March 20, 2024 | -2.325M |
| March 19, 2024 | -2.086M |
| March 18, 2024 | -2.347M |
| March 15, 2024 | -2.412M |
| March 14, 2024 | -2.021M |
| March 13, 2024 | -1.869M |
| March 12, 2024 | -1.956M |
| March 11, 2024 | -1.804M |
| March 08, 2024 | -1.826M |
| March 07, 2024 | -1.912M |
| March 06, 2024 | -1.782M |
| March 05, 2024 | -1.782M |
| March 04, 2024 | -1.348M |
| March 01, 2024 | -0.9349M |
| February 29, 2024 | -0.8915M |
| February 28, 2024 | -1.430M |
| February 27, 2024 | -1.094M |
| February 26, 2024 | -1.786M |
| February 23, 2024 | -2.159M |
| February 22, 2024 | -2.122M |
| February 21, 2024 | -2.103M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-20.59M
Minimum
Jul 22 2022
57.43M
Maximum
Aug 04 2022
1.962M
Average
1.944M
Median
May 13 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.654M |
| Palatin Technologies Inc | 20.69M |
| iBio Inc | 16.31M |
| Theriva Biologics Inc | -13.25M |
| Oragenics Inc | 2.992M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.592M |
| Total Expenses (Quarterly) | 7.694M |
| EPS Diluted (Quarterly) | -3.94 |
| Earnings Yield | -1.01K% |
| Normalized Earnings Yield | -3326.82 |